Sijia Duan

1 Minde Road
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum to "circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain" [Int. J. Biol. Macromol., 343 (2026) 149699].

Corrigendum to "circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain" [Int. J. Biol. Macromol., 343 (2026) 149699].

Journal: International journal of biological macromolecules

Published: April 12, 2026

Orchestrating diabetic wound repair via mitochondria-targeted delivery of dihydromyricetin with tailored ADSC-derived biohybrid nanovesicles.

Orchestrating diabetic wound repair via mitochondria-targeted delivery of dihydromyricetin with tailored ADSC-derived biohybrid nanovesicles.

Journal: Materials today. Bio

Published: December 08, 2025

circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain.

circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain.

Journal: International journal of biological macromolecules

Published: July 15, 2025

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.

Journal: Cancer chemotherapy and pharmacology

Published: October 12, 2022

Downregulation of ACC expression suppresses cell viability and migration in the malignant progression of breast cancer.

Downregulation of ACC expression suppresses cell viability and migration in the malignant progression of breast cancer.

Journal: Experimental and therapeutic medicine

Published: September 05, 2022

SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.

SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.

Journal: Breast cancer (Tokyo, Japan)

Published: February 27, 2020

Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR-7.

Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR-7.

Journal: FEBS open bio

Published: November 12, 2019

Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials.

Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials.

Journal: Breast cancer research and treatment

Published: September 24, 2019

EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis.

EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis.

Journal: International journal of molecular medicine

Published: September 20, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026